Occasionally I co-author articles and papers.
| Type | Titel | Journal or event | Date | Link |
|---|---|---|---|---|
| Article/Book | Patient Involvement in Health Technology Assessment | Springer Nature | 2026 | Link |
| Article | Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today? | Springer Nature, Therapeutic Innovation &Regulatory Science | April 2025 | Link |
| Article | Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape. | Cambridge University Press | November 2024 | Link |
| Paper | Patient involvement in HTA in Europe Recommendations from a 360° perspective view of current patient involvement practices. | Published by HTAi | October 2023 | Link |
| Article | Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today? | Springer Nature, Therapeutic Innovation &Regulatory Science | April 2025 | Link |
| Article | Building from Patient Experiences to Deliver Patient-Focused Healthcare Systems in Collaboration with Patients: A Call to Action. | Springer Nature, Therapeutic Innovation & Regulatory Science | Juli 2022 | Link |
| Presentation | Health Technology Assessment: Global alignment of systems, stakeholders and emerging trends. | Oxford University: The presentation was part of the "Economics and Regulation in Translational Science module" which is part of the MSc in Translational Health Sciences. | December 2021 | The link leads to a Podcast with a recording of the presentation. Neil starts around 48 seconds after the beginning of the podcast. Link |
| Paper | Deep Dive; PPI abroad: A patient advocacy perspective. The evolving practice of patient and public involvement in Europe and The United States | Swiss clinical trial platform - Regulatory Affairs Watch, Issue 6 | October 2021 | Link |
| Report | Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19. | ZENDO | September 2021 | Link |
| Article | Valuing patient engagement: reflexive learning in evidence generation practices for health technology assessment. | Social Science & Medicine, volume 280 | Juli 2021 | Link |
| Article | Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action. | Springer Nature, Therapeutic Innovation & Regulatory Science | Mai 2021 | Link |
| Article | The Role of Patient Experience in the Value Assessment of Complex Technologies - Do HTA Bodies Need to Reconsider How Value is Assessed? | Health Policy, Volume 125, Issue 5 | Mai 2021 | Link |
| Research paper | Understanding multi‐stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed‐methods study. | Wiley Online Library | February 2021 | Link |
| Book chapter | Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments. | Springer Nature | Juli 2018 | Link |
| Book chapter | What do stakeholders expect from patient engagement: Are these expectations being met? | National Library of Medicine | June 2018 | Link |
| Book chapter | Patient Involvement in Health Technology Assessment pp 419-427: Reflections for Future Development - SpringerMay, 2017LinkArtikelPatient Centricity and Pharmaceutical Companies: Is It Feasible? | Springer Nature | May 2017 | Link |
| Book chapter | Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group. | January 2016 | Link | |
| Book chapter | Moving Center Stage: patients claim their role in healthcare. | Farmeconomia -Healtheconomics and therapeutic healthcare. | March 2016 | Link |